E. May

Demographics of a large cohort of urban chronic hepatitis C patients

J. Janisse, R. Dhar, M. Ehrinpreis, 2008, Hepatology international.

Unique case of presumed lisinopril-induced hepatotoxicity.

Dongping Shi, S. Sethi, E. May, 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Profound jaundice in a patient with acute hepatitis C

E. May, Raxitkumar Jinjuvadia, Prateek Lohia, 2013, BMJ Case Reports.

Racial diversity in mortality and morbidity in urban patients with hepatitis C

M. Ehrinpreis, S. Benjaram, E. May, 2016, Journal of viral hepatitis.

Interferon (IFN) Based Treatment of African Americans with Chronic Hepatitis C (CHC) in an Urban Clinic: Improving Response with Advances in Therapy

M. Ehrinpreis, E. May, M. Mutchnick, 2015 .

Effect of Treatment for CHC on Liver Disease Progression and Hepatocellular Carcinoma Development in African Americans

M. Ehrinpreis, E. May, M. Mutchnick, 2015, Journal of clinical and translational hepatology.

Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C.

M. Ehrinpreis, E. May, M. Mutchnick, 2013, World journal of gastroenterology.

Do nutraceutics play a role in the prevention and treatment of colorectal cancer?

E. May, A. Majumdar, B. Markle, 2010, Cancer and Metastasis Reviews.

A Review on ACE-inhibitor Associated Hepatoxicity: 372

R. Fontana, S. Sethi, E. May, 2009 .